To the Editor: This double-blind study enrolled 157 patients with chronic schizophrenia and schizoaffective disorder and compared the efficacy and the safety of three atypical antipsychotics (clozapine, olanzapine, and risperidone) with one another and with haloperidol. The analysis of the results was based on two statistical approaches: 1) analysis of covariance for determining change over time in symptom scores, with baseline severity as a covariate, and 2) random regression with hierarchical linear modeling. As the authors stated in their section on Statistical Analyses, after a preliminary analysis of the results, "Hierarchical linear modeling analysis was adopted as the primary statistic for our study" (p. 257) and was in fact used to test the significance of differences in symptom severity.